AngioDynamics Sees FY24 Sales Of $328M-$333M Versus Consensus Of $323M, Adjusted EPS Loss Of $(0.28)-$(0.34) Versus Consensus Of $(0.08)
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics has projected its FY24 sales to be between $328M-$333M, which is higher than the consensus estimate of $323M. The company also expects its adjusted EPS to be between $0.28-$0.34.
July 12, 2023 | 11:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AngioDynamics' higher than expected FY24 sales and EPS projections could positively impact its stock price.
AngioDynamics' FY24 sales and EPS projections are higher than the consensus estimates. This positive outlook could increase investor confidence and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100